We read with great interest the article by Ferriera et al 1 reporting a significant elevation of circulating endothelial microparticles (EMPs) strictly correlated with postmeal increase in serum triglycerides in healthy normolipidemic subjects after a single high-fat meal. The results of the study add to the long list of previous research demonstrating impairment of endothelial functions after a single high-fat meal in otherwise healthy subjects. Some aspects of this work deserve further comment.
Response
We read with interest the comments of Guigliano and colleagues concerning our recent publication on postprandial elevation of endothelial microparticles (EMPs) after a high-fat meal. 1 We apologize for our factual error about the percentage of energy units from fat in the protocol, which should read 45%.
They questioned whether the elevated EMPs represent a cause or consequence of the endothelial dysfunction. Our studies indicate that EMPs arise from endothelial cells (ECs) in response to activation or apoptosis. 2 Thus, they are a result and not a cause of the endothelial dysfunction; however, cell-derived microparticles in the plasma of patients with acute coronary syndrome were shown to impair EC function. 3 It remains to be seen whether postprandial EMPs are also toxic to ECs.
Guigliano et al have suggested that postprandial EC dysfunction may be mediated by cytokines, such as tumor necrosis factor-␣ or interleukin-6. We did not measure cytokines in our study, therefore, we cannot confirm their findings. 4 EMPs are released from disturbed ECs and carry markers of the parent EC; they may also reflect the status of the EC. They are emerging as a promising marker of EC disturbances. 2 Giugliano et al draw attention to their work showing a postprandial rise in soluble EC markers ICAM-1 and VCAM-1. We did not discuss the extensive literature on soluble markers of EC dysfunction in our article, but we recently reviewed them along with EMPs. 2 These 2 forms arise by different mechanisms: EMPs rise by vesiculation and soluble markers by proteolysis. It is important to distinguish them because their sensitivity, specificity, and biological function may differ. So far, no systematic comparison between these 2 types of markers has been reported. We have found that "soluble" markers VCAM and ICAM are at least in part EMP bound. 2 In summary, the observations of Giugliano et al are complementary to ours. The challenges facing EMP studies are (1) delineation of natural functions of EMPs, now believed to play a role as diffusible biomessengers carrying various signaling molecules that participate in atherosclerosis, thrombosis, and inflammation; and (2) clarification of which methodology, EMPs or soluble markers, is superior. It is likely that some combination of methods may provide maximum information on EC disturbances in health and disease.
